Evaluation and management of the treatment-resistant anxiety disorder patient.
Effective evaluation and management of patients with anxiety disorders require an integrated theoretical model that predicts risk for the disorder as a consequence of constitutional vulnerability shaped by developmental experience and activated or influenced by environmental factors. From this perspective, the author describes a rational therapeutic strategy with treatment-resistant patients. He particularly urges a careful evaluation of risk factors and associated conditions that may contribute to persisting distress.
Rosenbaum
J F
JF
Massachusetts General Hospital, Boston 02114.
D000328:Adult; D001008:Anxiety Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D016584:Panic Disorder / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D010698:Phobic Disorders / Q000175:diagnosis; D011369:Professional-Patient Relations; D012931:Social Environment